Now available from Anachem, the Rainin Liquidator 96 is a fast, ready-to-use manual bench top pipetting system. Accurate and efficient, it maximizes your workflow, without the need for complicated programming or dedicated technician time. Liquidator 96 truly bridges the gap
Canadian-based InSymbiosis Discovery (InSymbiosis) is pleased to announce their participation at BioPartnering Europe.The purpose of this meeting is to bring together innovative and emerging companies in the life science industries with key members of the pharmaceutical, venture capital, and finance
Lumen Biomedical, a medical device company, has received the FDA clearance for the LBI embolectomy system for use in the removal of fresh, soft emboli and thrombi from vessels in the peripheral vasculature.
Icagen, a biopharmaceutical company, has initiated a Phase II proof-of-concept clinical trial to evaluate the safety and efficacy of senicapoc, the company's orally available small molecule inhibitor of the KCa3.1 potassium ion channel, in patients with allergic asthma.
Abbott, a healthcare company, has opened new development laboratories and a pilot plant facility that will research groundbreaking technologies and test large-scale production of newly developed drug formulations. This expansion is part of Abbott's global drug delivery business, Soliqs, which
Boston Scientific, a developer, manufacturer and marketer of medical devices, has completed enrollment in the Perseus trial, designed to evaluate the company's third-generation Taxus Element paclitaxel-eluting coronary stent.
Pathway Medical Technologies, a provider of medical devices for the treatment of arterial disease, has appointed Paul Buckman as its new president and CEO.
Natus Medical, a provider of neurodiagnostic systems, has agreed to acquire certain assets from BrainZ Instruments, a New Zealand-based medical technology company.
Xcorporeal, a medical device company, has appointed Kelly McCrann as its new chairman and CEO. Mr McCrann replaces Daniel Goldberger who has been the company's acting CEO since February 2008 and Terren Peizer, who has been chairman since the company's
Chembio Diagnostics, a provider of proprietary rapid diagnostic tests, has obtained approval from the FDA to extend the testing age range for its HIV rapid point-of-care tests to individuals 13 years of age and older.
Calistoga Pharmaceuticals, a developer of medicines for the treatment of cancer and inflammatory diseases, has appointed Carol Gallagher as its new CEO.
Sinobiomed, a developer of genetically engineered recombinant protein drugs and vaccines, has appointed Lionel Choong as its new CFO. In addition, Mr Choong has been appointed to the company's audit committee.
Moraga Biotechnology, an adult stem cell company, has licensed its blood-derived blastomere-like stem cells to Pharmacells headquartered in Glasgow, Scotland.
EpiCept, a specialty pharmaceutical company, has announced that the European Commission has granted a full marketing authorization in the form of a positive commission decision, for Ceplene for the remission maintenance and prevention of relapse in adult patients with acute
Watson Pharmaceuticals, a specialty pharmaceutical company, has reported positive clinical pharmacokinetic data on oxybutynin chloride topical gel, its investigational therapy for overactive bladder.
Neotropix, a clinical-stage development company focused on neuroendocrine cancer treatments, has started enrolling neuroendocrine cancer patients into an expanded clinical trial of its lead candidate, NTX-010, a tumor-selective naturally-occurring oncolytic virus.
Cenomed BioSciences, a majority-owned subsidiary of Abraxis BioScience, and TorreyPines Therapeutics, a biopharmaceutical company, have signed an exclusive licensing agreement.
